ArticleClinical drug investigation2022

Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database.

Tingxi Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.